[1]CurrentPatentAssignee:SEMICONDUCTORENERGYLABORATORYCOLTD-JP2020/66609,2020,ALocationinpatent:Paragraph0162-0166
[1]CurrentPatentAssignee:REMIXTHERAPEUTICS-WO2021/174167,2021,A1Locationinpatent:Page/Pagecolumn239;242
912773-21-8
21943-16-8
916791-07-6
1082843-70-6
1206250-01-2
55233-47-1
6158-54-9 | Benzoic acid, 4-benzoyl-, methyl ester | AA003ACU | MFCD00197207
1343662-35-0 | 3-Bromo-4-((tert-butoxycarbonyl)amino)benzoic acid | AA003AHZ | MFCD17170504
61791-12-6 | Castor oil polyoxyethylene ether | AA003AOC | MFCD00130879
26807-65-8 | Indapamide | AA003AUJ | MFCD00079375
22013-33-8 | 2,3-dihydro-1,4-benzodioxin-6-amine | AA003AXM | MFCD00006824
88-24-4 | 6,6'-Methylenebis(2-(tert-butyl)-4-ethylphenol) | AA003B0L | MFCD00026296
351003-45-7 | 2-Bromo-4-fluorobenzenesulfonyl chloride | AA003B3O | MFCD03094149
6872-06-6 | 2-Methylindoline | AA003B6I | MFCD00005706
120570-09-4 | (+)-N-(1(S)-Phenylethyl)-1-azabicyclo[2.2.2]octan-3(R)-amine hydrochloride | AA003BAE | MFCD01321399
104322-63-6 | (1S)-(+)-(10-Camphorsulfonyl)oxaziridine | AA003BF4 | MFCD21332910